Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Kuczyk

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|January 1, 1995
p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladderJ Serth, M A Kuczyk, C Bokemeyer, et al.
Pathology, Research and Practice|November 1, 1994
Overexpression of the p53 oncoprotein in carcinoma in situ of the testisM A Kuczyk, J Serth, C Bokemeyer, et al.
Aktuelle Urologie|August 23, 2012
[Partial nephrectomy after neoadjuvant administration of sunitinib facilitates preservation of a solitary kidney]C von Klot, J U Becker, V Grünwald, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parametersC Bokemeyer, M A Kuczyk, J Serth, et al.
World Journal of Urology|January 1, 1996
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumorsC Bokemeyer, J T Hartmann, M A Kuczyk, et al.
British Journal of Urology|September 2, 1998
A questionnaire-based outcome analysis of the Stamey bladder neck suspension procedure for the treatment of urinary stress incontinence: the Hannover experienceM A Kuczyk, S Klein, V Grünewald, et al.
Der Urologe. Ausg. A|March 1, 1995
[Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder]M A Kuczyk, J Serth, C Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomyM A Kuczyk, J Serth, C Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
p53 overexpression as a prognostic factor for advanced stage bladder cancerM A Kuczyk, C Bokemeyer, J Serth, et al.
British Journal of Cancer|May 14, 1998
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancerC Bokemeyer, C C Berger, J T Hartmann, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|January 1, 1995
p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladderJ Serth, M A Kuczyk, C Bokemeyer, et al.
Pathology, Research and Practice|November 1, 1994
Overexpression of the p53 oncoprotein in carcinoma in situ of the testisM A Kuczyk, J Serth, C Bokemeyer, et al.
Aktuelle Urologie|August 23, 2012
[Partial nephrectomy after neoadjuvant administration of sunitinib facilitates preservation of a solitary kidney]C von Klot, J U Becker, V Grünwald, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parametersC Bokemeyer, M A Kuczyk, J Serth, et al.
World Journal of Urology|January 1, 1996
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumorsC Bokemeyer, J T Hartmann, M A Kuczyk, et al.
British Journal of Urology|September 2, 1998
A questionnaire-based outcome analysis of the Stamey bladder neck suspension procedure for the treatment of urinary stress incontinence: the Hannover experienceM A Kuczyk, S Klein, V Grünewald, et al.
Der Urologe. Ausg. A|March 1, 1995
[Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder]M A Kuczyk, J Serth, C Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomyM A Kuczyk, J Serth, C Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
p53 overexpression as a prognostic factor for advanced stage bladder cancerM A Kuczyk, C Bokemeyer, J Serth, et al.
British Journal of Cancer|May 14, 1998
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancerC Bokemeyer, C C Berger, J T Hartmann, et al.
Pageof 10